18 Jul RheumaGen
Posted at 20:09h
in
Richard Freed, CEO
Oct. 6 | 9:00am | FLW Ballroom G
Aurora, CO
(Private)
RheumaGen is a Colorado biotech company founded in 2019 that is engineering a cure for rheumatoid arthritis (RA), multiple sclerosis (MS) and other major autoimmune diseases using HLA gene editing. Put simply, RheumaGen can make small changes to the HLA gene, which will “turn off” the body’s ability to continue attacking itself. Our lead indication targets the ~1 million RA patients in the US, EU, Australia and Japan who are refractory to multiple biologics and face the most severe symptoms.